Miniaturized Fluid Delivery and Analysis System

ABSTRACT

The present invention provides a method for combining a fluid delivery system with an analysis system for performing immunological or other chemical of biological assays. The method comprises a miniature plastic fluidic cartridge containing a reaction chamber with a plurality of immobilized species, a capillary channel, and a pump structure along with an external linear actuator corresponding to the pump structure to provide force for the fluid delivery. The plastic fluidic cartridge can be configured in a variety of ways to affect the performance and complexity of the assay performed.

CROSS-REFERENCE TO RELATED APPLICATION

This application claims priority to U.S. patent application Ser. No.10/437,046, filed on May 14, 2003. This application is a continuation ofU.S. patent application Ser. No. 11/505,303 filed on Aug. 15, 2006,which is a divisional of U.S. patent application Ser. No. 10/437,046,filed on May 14, 2003, which are hereby incorporated by reference hereinin their entirety.

BACKGROUND OF THE INVENTION 1. Field of the Invention

This invention relates to a system comprising a fluid delivery andanalysis cartridge and an external linear actuator. More particularly,the invention relates to a system for carrying out various processes,including screening, immunological diagnostics, DNA diagnostics, in aminiature fluid delivery and analysis cartridge.

Recently, highly parallel processes have been developed for the analysisof biological substances such as, for example, proteins and DNA. Largenumbers of different binding moieties can be immobilized on solidsurfaces and interactions between such moieties and other compounds canbe measured in a highly parallel fashion. While the sizes of the solidsurfaces have been remarkably reduced over recent years and the densityof immobilized species has also dramatically increased, typically suchassays require a number of liquid handling steps that can be difficultto automate without liquid handling robots or similar apparatuses.

A number of microfluidic platforms have recently been developed to solvesuch problems in liquid handling, reduce reagent consumptions, and toincrease the speed of such processes. Examples of such platforms aredescribed in U.S. Pat. Nos. 5,856,174 and 5,922,591. Such a device waslater shown to perform nucleic acid extraction, amplification andhybridization on HIV viral samples as described by Anderson et al,“Microfluidic Biochemical Analysis System”, Proceeding of the 1997International Conference on Solid-State Sensors and Actuators,Tranducers '97, 1997, pp. 477-480. Through the use of pneumaticallycontrolled valves, hydrophobic vents, and differential pressure sources,fluid reagents were manipulated in a miniature fluidic cartridge toperform nucleic acid analysis.

Another example of such a microfluidic platform is described in U.S.Pat. No. 6,063,589 where the use of centripetal force is used to pumpliquid samples through a capillary network contained on compact-discliquid fluidic cartridge. Passive burst valves are used to control fluidmotion according to the disc spin speed. Such a platform has been usedto perform biological assays as described by Kellog et al, “CentrifugalMicrofluidics: Applications,” Micro Total Analysis System 2000,Proceedings of the uTas 2000 Symposium, 2000, pp. 239-242. The furtheruse of passive surfaces in such miniature and microfluidic devices hasbeen described in U.S. Pat. No. 6,296,020 for the control of fluid inmicro-scale devices.

An alternative to pressure driven liquid handling devices is through theuse of electric fields to control liquid and molecule motion. Much workin miniaturized fluid delivery and analysis has been done using theseelectro-kinetic methods for pumping reagents through a liquid medium andusing electrophoretic methods for separating and perform specific assaysin such systems. Devices using such methods have been described in U.S.Pat. No. 4,908,112, U.S. Pat. No. 6,033,544, and U.S. Pat. No.5,858,804.

Other miniaturized liquid handling devices have also been describedusing electrostatic valve arrays (U.S. Pat. No. 6,240,944), Ferrofluidmicropumps (U.S. Pat. No. 6,318,970), and a Fluid Flow regulator (U.S.Pat. No. 5,839,467).

The use of such miniaturized liquid handling devices has the potentialto increase assay throughput, reduce reagent consumption, simplifydiagnostic instrumentation, and reduce assay costs.

SUMMARY OF THE INVENTION

The system of the invention comprises a plastic fluidic device having atleast one reaction chamber connected to pumping structures throughcapillary channels and external linear actuators. The device comprisestwo plastic substrates, a top substrate and a bottom substratecontaining capillary channel(s), reaction chamber(s), and pump/valvechamber(s)—and a flexible intermediate interlayer between the top andbottom substrate which provides providing a sealing interface for thefluidic structures as well as valve and pump diaphragms. Passive checkvalve structures are formed in the three layer device by providing ameans for a gas or liquid to flow from a channel in the lower substrateto a channel in the upper substrate by the bending of the interlayerdiaphragm. Furthermore flow in the opposite direction is controlled byrestricting the diaphragm bending motion with the lower substrate.Alternatively check valve structures can be constructed to allow flowfrom the top substrate to the bottom substrate by flipping the devicestructure. Pump structures are formed in the device by combining a pumpchamber with two check valve structures operating in the same direction.A hole is also constructed in the lower substrate corresponding to thepump chamber. A linear actuator—external to the plastic fluidicdevice—can then be placed in the hole to bend the pump interlayerdiaphragm and therefore provide pumping action to fluids within thedevice. Such pumping structures are inherently unidirectional.

In one embodiment the above system can be used to perform immunoassaysby pumping various reagents from an inlet reservoir, through a reactionchamber containing a plurality of immobilized antibodies or antigens,and finally to an outlet port. In another embodiment the system can beused to perform assays for DNA analysis such as hybridization to DNAprobes immobilized in the reaction chamber. In still another embodimentthe device can be used to synthesize a series of oligonucleotides withinthe reaction chamber. While the system of the invention is well suitedto perform solid-phase reactions within the reaction chamber and providethe means of distributing various reagents to and from the reactionchamber, it is not intended to be limited to performing solid-phasereactions only.

The system of the invention is also well suited for disposablediagnostic applications. The use of the system can reduce theconsumables to only the plastic fluidic cartridge and eliminate anycross contamination issues of using fixed-tipped robotic pipettes commonin high-throughput applications.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1A is a top view of a pump structure within the plastic fluidicdevice of the invention.

FIG. 1B is a cross section view of the pump structure within the plasticfluidic device of the invention.

FIG. 2 is a top view of a plastic fluidic device of the inventionconfigured as a single-fluid delivery and analysis device.

FIG. 3 is a top view of a plastic fluidic device of the inventionconfigured as a 5-fluid delivery and analysis device.

FIG. 4 is a top view of a plastic fluidic device of the inventionconfigured as a re-circulating 3-fluid delivery and analysis device.

DETAILED DESCRIPTION OF THE INVENTION

The system of the invention comprises a plastic fluidic cartridge and alinear actuator system external to the fluidic cartridge. FIG. 1A showsa cross-sectional view of a pump structure formed within the fluidiccartridge of the invention. The plastic fluidic cartridge comprisesthree primary layers: an upper substrate 21, a lower substrate 22, and aflexible intermediate interlayer 23, as shown in FIG. 1B. The threelayers can be assembled by various plastic assembly methods such as, forexample, screw assembly, heat staking, ultrasonic bonding, clamping, orsuitable reactive/adhesive bonding methods. The upper and lowersubstrates, depicted as 21 and 22 in FIG. 1B, both contain a variety offeatures that define channels of capillary dimensions as well as pumpchambers, valve chambers, reaction chambers, reservoirs, andinlet/outlet ports within the cartridge. FIG. 1B shows a top view of thepump structure of FIG. 1A. The pump is defined by a pump chamber 14 andtwo passive check valves 15 that provide a high resistance to flow inone direction only. Passive check valves 15 comprise a lower substratechannel 13 and an upper substrate channel 11 separated by interlayer 23such that holes through interlayer 23, depicted as holes 12 in FIG. 1B,are contained within upper substrate channel 11 but not within lowersubstrate channel 13. Such check valve structures provide a lowresistance to a gas/liquid flowing from lower substrate channel 13 toupper substrate channel 11 and likewise provide a high resistance to agas/liquid flowing from upper substrate channel 11 to lower substratechannel 13. Pump chamber 14 comprises an upper substrate chamber and ahole 141 in lower substrate 22 to free interlayer 23 to act as adiaphragm 25, as depicted in FIG. 1B. A linear actuator 24 external tothe fluidic cartridge can then be placed in the hole 131 to benddiaphragm 25 and therefore provide the necessary force to deform thediaphragm.

FIG. 2 shows a top view of a plastic fluidic cartridge of the inventionconfigured as a single-fluid delivery and analysis device. Fluid isfirst placed into the reservoir 31 manually or automated using a pipetteor similar apparatus. A pump structure 32 similar to that of FIG. 1B iscontained within the device. By repeatedly actuating an external linearactuator, fluid in reservoir 31 is pumped through the pump structure 32,the capillary channel 33 and into the reaction chamber 34. Reactionchamber 34 contains a plurality of immobilized bio-molecules 35 forspecific solid-phase reactions with said fluid. After a specifiedreaction time, the fluid is pumped through reaction chamber 34 and outthe exit port 36.

Upper substrate 21 and lower substrate 22 of the plastic fluidiccartridge of the invention can be constructed using a variety of plasticmaterials such as, for example, polymethyl-methacrylate (PMMA),polystyrene (PS), polycarbonate (PC), Polypropylene (PP),polyvinylchloride (PVC). In the case of optical characterization ofreaction results within a reaction chamber, upper substrate 21 ispreferably constructed out of a transparent plastic material.Capillaries, reaction chambers, and pump chambers can be formed in uppersubstrate 21 and lower substrate 22 using methods such as injectionmolding, compression molding, hot embossing, or machining. Thicknessesof upper substrate 21 and lower substrate 22 are suitably in, but notlimited to, the range of 1 millimeter to 3 millimeter in thickness.Flexible interlayer 23 can be formed by a variety of polymer and rubbermaterials such as latex, silicone elastomers, polyvinylchloride (PVC),or fluoroelastomers. Methods for forming the features in interlayer 23include die cutting, rotary die cutting, laser etching, injectionmolding, and reaction injection molding.

Linear actuator 24 of the present invention, as depicted in FIG. 1B, ispreferred to be, but not limited to, an electromagnetic solenoid. Othersuitable linear actuators include a motor/cam/piston configuration, apiezoelectric linear actuator, or motor/linear gear configuration.

The invention will further be described in a series of examples thatdescribe different configurations for performing different analysesusing the plastic fluidic cartridge and external linear actuator of thisinvention.

Example 1 Immunological Assay

The plastic fluidic cartridge, as shown in FIG. 2, can be utilized toperform immunological assays within reaction chamber 34 by immobilizinga plurality of bio-molecules such as different antibodies 35. In oneexemplary embodiment, a sample containing an unknown concentration of aplurality of antigens or antibodies is first placed within reservoir 31.The external linear actuator is then repeatedly actuated to pump thesample from reservoir 31 to reaction chamber 34. The sample is thenallowed to react with the immobilized antibodies 35 for a set reactiontime. At the end of the set reaction time, the sample is then excludedfrom reaction chamber 34 through exit port 36. A wash buffer is thenplaced in reservoir 31 and the external linear actuator is repeatedlyactuated to pump the wash buffer through reaction chamber 34 and out theexit port 36. Such wash steps can be repeated as necessary. A solutioncontaining a specific secondary antibody conjugated with a detectablemolecule such as a peroxidase enzyme, alkaline phosphatase enzyme, orfluorescent tag is placed into reservoir 31. The secondary antibodysolution is then pumped into reaction chamber 34 by repeatedly actuatingthe linear actuator. After a predetermined reaction time, the solutionis pumped out through exit port 36. Reaction chamber 34 is then washedin a similar manner as previously describe. In the case of an enzymeconjugate, a substrate solution is placed into reservoir 31 and pumpedinto reaction chamber 34. The substrate will then react with any enzymecaptured by the previous reactions with the immobilized antibodies 35providing a detectable signal. For improved assay performance, reactionchamber 34 can be maintained at a constant 37.degree. C.

According to the present invention, the plastic fluidic cartridge neednot be configured as a single-fluid delivery and analysis device. FIG. 3shows a plastic cartridge configured as a five fluid delivery andanalysis device. Such a device can perform immunological assays, such ascompetitive immunoassay, immunosorbent immunoassay, immunometricimmunoassay, sandwich immunoassay and indirect immunoassay, by providingimmobilized antibodies in reaction chamber 46. Here reaction chamber 46is not configured as a wide rectangular area, but a serpentine channelof dimensions similar to capillary dimension. This configurationprovides more uniform flow through the reaction chamber at the expenseof wasted space. For example, during immunoassays, a sample containingunknown concentrations of a plurality of antigens or antibodies isplaced in reservoir 41. A wash buffer is placed in reservoir 42.Reservoir 43 remains empty to provide air purging. A substrate solutionspecific to the secondary antibody conjugate is placed in reservoir 44.The secondary antibody conjugate is placed in reservoir 45. Eachreservoir is connected to a pump structure 1′ similar to that of FIG. 1.Pump structures 1′ provide pumping from reservoirs 41, 42, 43, 44, and45 through reaction chamber 46 to a waste reservoir 49. A secondaryreaction chamber 47 is provided for negative control and is isolatedfrom the sample of reservoir 41 by check valve 48. The protocol forperforming immunoassays in this device is equivalent to that describedpreviously for the single-fluid configuration with the distinctdifference that each separated reagent is contained in a separatereservoir and pumped with a separate pump structure using a separateexternal linear actuator. First, an external linear actuatorcorresponding to a pump connected to reservoir 41 is repeatedly actuateduntil a sample fluid fills reaction chamber 46. After a predeterminedreaction time, the sample fluid is pumped to waste reservoir 49 usingeither a pump connected to sample reservoir 41 or a pump connected toair purge reservoir 43. Next the wash buffer is pumped into reactionchamber 46 by repeatedly actuating the external actuator correspondingto a pump structure connected to wash reservoir 42. The wash and/or airpurge cycle can be repeated as necessary. A secondary antibody solutionis then pumped into reaction chamber 46 by repeatedly actuating theexternal linear actuator corresponding to a pump structure connected toreservoir 45. After a predetermined reaction time, the secondaryantibody solution is excluded from reaction chamber 46 either by a pumpconnected to reservoir 45 or a pump connected to air purge reservoir 43.Reaction chamber 46 is then washed as before. The substrate is pumpedinto reaction chamber 46 by repeatedly actuating a linear actuatorcorresponding to a pump connected to reservoir 44. After a predeterminedreaction time, the substrate is excluded from reaction chamber 46 andreplaced with wash buffer from reservoir 42. Results of the immunoassaycan then be confirmed by optical measurements through upper substrate21.

Furthermore, the reactions performed with the plastic fluidic cartridgeof the invention need not be limited to reactions performed instationary liquids. FIG. 4 shows a plastic fluidic cartridge accordingto the invention, configured to provide continuous fluid motion throughreaction chamber 55. In this configuration, reservoirs 51, 52, and 53are connected to separate pump structures similar to those of the fivefluid configuration of FIG. 3, but in this case the pump structures areconnected to an intermediate circulation reservoir 56. For example, pumpstructure 57 is connected to circulation reservoir 56 to providecontinuous circulation of fluid from circulation reservoir 56 throughreaction chamber 55 and returning to circulation reservoir 56. In thismanner, a fluid can be circulated through reaction chamber 55 withoutstopping. Such a fluid motion can provide better mixing, fasterreactions times, and complete sample reaction with immobilized speciesin reaction chamber 55. Pump structure 58 is connected such that itprovides pumping of fluids from circulation reservoir 56 to wastereservoir 54. Immunological assays similar to those described above canbe performed in this device by immobilizing antibodies in reactionchamber 55 placing the sample containing unknown concentrations ofantigens or antibodies in the circulation reservoir 56, placing asolution of secondary antibody conjugate in reservoir 52, placing asubstrate solution in reservoir 53, and placing a wash buffer inreservoir 51. The remaining protocol is identical to the above methodwith the addition of transferring fluids to and from the circulationreservoir 56 and continuously circulating during all reaction times.

Example 2 DNA Hybridization

The system of the present invention can also be used to perform DNAhybridization analysis. Using the plastic cartridge of FIG. 4, aplurality of DNA probes are immobilized in reaction chamber 55. A samplecontaining one or more populations of fluorescently tagged, amplifiedDNA of unknown sequence is placed in reservoir 52. A first stringencywash buffer is placed in reservoir 51. A second stringency wash bufferis placed in reservoir 53. Reaction chamber 55 is maintained at aconstant temperature of 52.degree. C. The sample is transferred tocirculation reservoir 56 by repeatedly actuating a linear actuatorcorresponding to a pump structure connected to reservoir 52. The sampleis then circulated through reaction chamber 55 by repeatedly actuating alinear actuator corresponding to pump structure 57. The sample iscirculated continuously for a predetermined hybridization time typicallyfrom 30 minutes to 2 hours. The sample is then excluded from thecirculation reservoir 56 and reaction chamber 55 by actuating pumpstructures 57 and 58 in opposing fashion. The first stringency washbuffer is then transferred to circulation reservoir 56 by repeatedlyactuating the linear actuator corresponding to the pump structureconnected to reservoir 51. The first stringency wash buffer is thencirculated through reaction chamber 55 in the same manner describedabove. After a predetermined wash time, the first stringency wash bufferis excluded from reaction chamber 55 and circulation reservoir 56 asdescribed above. A second stringency wash buffer is then transferred tocirculation reservoir 56 and circulated through reaction chamber 55 in amanner similar to that previously described. After the second washbuffer is excluded, the DNA hybridization results can be read byfluorescent imaging.

The invention being thus described, it will be obvious thatthe-invention may be varied in many ways. Such variations are not to beregarded as a departure from the spirit and scope of the invention, andall such modifications as would be obvious to one skilled in the art areintended to be included within the scope of the following claims.

1-11. (canceled)
 12. A method of performing immunological assay of afluid sample, wherein the method comprises the steps of: (a) pumpingsaid fluid sample from a fluid reservoir, where said fluid sample isplaced therein, to a reaction chamber, wherein said fluid reservoir andsaid reaction chamber are defined in a fluidic cartridge and saidreaction chamber comprises therein a plurality of immobilized species;(b) allowing said fluid sample to react with said plurality ofimmobilized species for a predetermined reaction time; and (c) excludingsaid fluid sample from said reaction chamber through an exit port. 13.The method, as recited in claim 12, further comprising the steps of: (d)placing an antibody solution containing a specific secondary antibodyconjugated with a detectable molecule into a fluid reservoir; (e)pumping said antibody solution from said fluid reservoir to saidreaction chamber; (f) pumping said antibody solution out through an exitport after a predetermined reaction time; and (g) providing a detectablesignal.
 14. The method as recited in claim 12, further comprising atleast a washing step of pumping a wash buffer placed in a fluidreservoir through said reaction chamber and out an exit port.
 15. Themethod as recited in claim 13, after step (c) and step (f), each furthercomprising a washing step of pumping a wash buffer placed in a fluidreservoir through said reaction chamber and out said exit port.
 16. Themethod, as recited in claim 12 or 14, wherein said fluid sample containsa plurality of different antibodies.
 17. The method, as recited in claim12, 13 or 15, wherein said detectable molecule is selected from thegroup consisting of peroxidase enzyme, alkaline phosphatase enzyme andfluorescent tag.
 18. The method, as recited in claim 17, after step (c),further comprising a step of pumping a substrate buffer placed in saidfluid reservoir to said reaction chamber to allow a substrate in saidsubstrate buffer to react with any enzyme captured in step (b) with saidimmobilized species providing a detectable signal.
 19. The method, asrecited in claim 17, after step (f), further comprising a step ofpumping a substrate buffer placed in said fluid reservoir to saidreaction chamber to allow a substrate in said substrate buffer to reactwith any enzyme captured in step (e).
 20. The method, as recited inclaim 12 or 14, wherein said fluid reservoir, said reaction chamber andsaid exit port are connected by one or more channels of capillarydimensions, wherein said fluidic cartridge includes a first substrate, asecond substrate and an flexible intermediate interlayer sealedlyinterfaced between said first substrate and said second substrate toform therein said fluid reservoir, said one or more channels, saidreaction chamber, and said exit port, and wherein said fluidic cartridgefurther provides a fluid flow controlling structure therein to restricta flow of said fluid sample through said reaction chamber via said oneor more channels in one direction only.
 21. The method, as recited inclaim 13 or 15, wherein said fluid reservoir, said reaction chamber andsaid exit port are connected by one or more channels of capillarydimensions, wherein said fluidic cartridge includes a first substrate, asecond substrate and an flexible intermediate interlayer sealedlyinterfaced between said first substrate and said second substrate toform therein said fluid reservoir, said one or more channels, saidreaction chamber, and said exit port, and wherein said fluidic cartridgefurther provides a fluid flow controlling structure therein to restricta flow of said fluid sample and said antibody solution through saidreaction chamber via said one or more channels in one direction only.22. The method as recited in claim 12, wherein said fluid samplecomprises a plurality of bio-molecules at unknown concentrations or ananalyte conjugated with a detectable molecule.
 23. The method as recitedin claim 12, wherein said immobilized species comprises a protein, anantibody, a nucleic acid, a DNA, a compound, or a combination thereof.